Rhabdomyosarcoma, the rare cancer that killed 'Blue Bloods' actor, explained

"Blue Bloods" actor and comedian Alex Duong recently died at 42 after a year-long battle with alveolar rhabdomyosarcoma, a ...

Carolyn Hax: Stepdad beat cancer, and he’s now bringing family to heel

Letter writer worries that mom “completely defers” to her husband, who has clamped down on everyone since his cancer ...
Medindia

After 60 Years, Metformin’s Blood Sugar-Lowering Mechanism May Finally Be Clear

Study suggests metformin may help regulate blood sugar through Rap1 signaling pathways in the hypothalamus, revealing a ...

Rhythm Pharmaceuticals Receives Positive CHMP Opinion for IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Patients wit…

European Commission decision anticipated in second quarter of 2026 -- BOSTON, March 26, 2026 (GLOBE NEWSWIRE) -- Rhythm ...

Rhythm Pharmaceuticals, Inc.: Rhythm Pharmaceuticals Receives Positive CHMP Opinion for IMCIVREE (setmelanotide) for the Treatment of Obesity and Control of Hunger in Patients ...

European Commission decision anticipated in second quarter of 2026 -- BOSTON, March 26, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutica ...
PharmExec

FDA Approves Expanded Indication for Imcivree as Treatment for Hypothalamic Obesity

Acquired hypothalamic obesity is typically precipitated by hypothalamic insult from tumors, treatment, trauma, stroke, or ...

Rhythm Pharmaceuticals Wins FDA Approval for IMCIVREE in Acquired Hypothalamic Obesity Launch

Rhythm Pharmaceuticals (NASDAQ:RYTM) announced that the U.S. Food and Drug Administration has approved IMCIVREE ...

Rhythm Wins FDA Nod for Hypothalamic Obesity Therapy

Detailed price information for Rhythm Pharmaceuticals Inc (RYTM-Q) from The Globe and Mail including charting and trades.
Fierce Pharma

Rhythm's Imcivree scores 'transformative' FDA approval in brain damage-related obesity

Rhythm Pharmaceuticals is switching up the tempo for its melanocortin-4 receptor (MC4R) agonist Imcivree. | The new FDA nod ...
The American Journal of Managed Care

FDA Approves Setmelanotide for Adult and Pediatric Patients With Acquired Hypothalamic Obesity

FDA approval establishes setmelanotide as the first labeled option for acquired hypothalamic obesity, addressing a population ...

Rhythm Pharma wins FDA approval for first-ever rare weight disorder therapy

The U.S. Food and Drug Administration (FDA) on Thursday approved an expanded indication for Rhythm Pharmaceuticals Inc.’s ...